InvestorsHub Logo
Followers 15
Posts 700
Boards Moderated 0
Alias Born 10/03/2017

Re: Number sleven post# 387985

Thursday, 09/01/2022 2:26:12 PM

Thursday, September 01, 2022 2:26:12 PM

Post# of 429097
"My question is are they going to?"

I think yes, and assume it's in the works.

Mochida launches once-daily Epadel on Sept. 12

From Pharma Japan: Mochida to Roll Out Once-Daily Epadel on Sept. 12

Mochida Pharmaceutical said on August 18 that a new once-daily soft capsule version of its hyperlipidemia drug Epadel (ethyl icosapentate) listed the same day will be available on September 12. https://pj.jiho.jp/article/247307



Coincidentally (or not?), this is the same date that Amarin CEO Karim Mikhail is presenting at H.C. Wainwright's 24th Annual Global Investment Conference.

Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim Mikhail, Amarin’s president and chief executive officer, is scheduled to participate at the H.C. Wainwright 24th Annual Global Investment Conference on September 12, 2022.

Date/Time: September 12, 2022, 9:00 a.m. ET/ 1:00 p.m. GMT+1


Perhaps we will hear something then. For whatever reason, they're not ready... guessing they are in discussions with FDA.

dogn
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News